Drug recall
Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Vial (NDC 0781-3074-71) and 10 mL vials (NDC…
FDA recall event 59816 · Class II · Sandoz, Inc
Key facts
| Event ID | 59816 |
|---|---|
| Recall numbers | D-1279-2011 |
| Recalling firm | Sandoz, Inc |
| Product type | Drugs |
| Products | Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Vial (NDC 0781-3074-71) and 10 mL vials (NDC 00781-3074-70), Manufactured in Canada by Sandoz Canada Inc. for Sandoz Inc., Princeton, NJ 08540 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Crystallization; higher than expected levels of crystals |
| Initiation date | Aug 25, 2011 |
| Termination date | Apr 13, 2012 |
| City | Princeton |
| State | NJ |
| Country | United States |
| FEI number | 3006697677 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports